Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00551954Phase 3Completed
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Acarbose with Placebo (2 arms). Primary endpoint: Forearm blood flow assessed by forearm occlusion plethysmography after a mixed meal at 20 weeks. Started Jul 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00551954.